<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30916120</article-id><article-id pub-id-type="pmc">6436773</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0404</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Postoperative Metabolic, Inflammation, and Atrial Fibrillation
Control: a Relentless Battle</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1132-9667</contrib-id><name><surname>Feguri</surname><given-names>Gibran Roder</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Franco</surname><given-names>Anna Carolina</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Cardiology and Cardiovascular Surgery Department, General
University Hospital, Universidade de Cuiab&#x000e1; (HGU-UNIC), Cuiab&#x000e1;, MT,
Brazil.</aff><aff id="aff2">
<label>2</label> Cardiovascular Surgery Department, General University Hospital,
Universidade de Cuiab&#x000e1; (HGU-UNIC), Cuiab&#x000e1;, MT, Brazil.</aff><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2019</year></pub-date><volume>34</volume><issue>2</issue><fpage>VI</fpage><lpage>VII</lpage><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions></article-meta></front><body><p>Trauma from cardiovascular surgery results in a well-known metabolic and inflammatory
response syndrome, in addition to insulin resistance (IR) and subsequent hyperglycemia.
This unfavorable "metabolic status" can last for approximately three weeks or more.
Prolonged preoperative fasting may worsen this syndrome, and hyperglycemia is an
independent factor for worse prognosis in patients undergoing cardiovascular surgery,
leading to prolonged hospital stay, higher infection rates and increased postoperative
morbidity and mortality<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>In spite of its significant benefits and technological innovations, cardiopulmonary
bypass plays an important role in the development of this syndrome as it causes the
release of proinflammatory cytokines and other chemical mediators that, in high
concentrations, are associated with organ dysfunction, coagulopathy, ischemia, and
adverse clinical outcomes<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>Postoperative atrial fibrillation (POAF) is a frequent complication of cardiovascular
surgery, especially with the use of cardiopulmonary bypass, although it features
multifactorial triggers. It has been associated with inflammation and can cause severe
discomfort, as well as increased chance of thromboembolic events, postoperative
morbidity and mortality and percentage of intensive care unit and hospital
readmission<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>Studies have shown that fasting abbreviation with carbohydrate-rich fluids improves IR
and promotes glycemic control, reduces the incidence of postoperative nausea and
vomiting, and reduces lean body mass loss-with subsequent increase in postoperative
muscle strength. In addition, it improves immune function maintenance in post-surgical
trauma and reduces length of hospital stay<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>In Brazil, the first study reporting preoperative fasting abbreviation with carbohydrate
(CHO) intake in cardiovascular surgery was published in 2012<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>, in which the ACERTO protocol (ACElera&#x000e7;&#x000e3;o
da Recupera&#x000e7;&#x000e3;o Total P&#x000f3;s-Operat&#x000f3;ria; an example of a
national multimodal protocol) was used<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. The intervention group showed favorable clinical and metabolic
outcomes and shorter hospital and intensive care unit length of stay; however, there was
no change in IR in the sample studied.</p><p>On the other hand, omega-3 polyunsaturated fatty acids (&#x003c9;-3 PUFA) are no longer
exclusive to clinical cardiology. In the last decade, &#x003c9;-3 PUFA have become an
important ally in postoperative inflammation and metabolic control in cardiovascular
surgery, as it is directly related to a reduction in proinflammatory cytokines and
incidence of postoperative arrhythmia, particularly postoperative atrial fibrillation.
The protective effects of this type of fish oil have also been observed in critically
ill patients in the intensive care unit, usually in parenteral nutrition
regimens<sup>[<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>Berger et al.<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup> conducted a novel study
in which they analyzed 28 patients undergoing coronary artery bypass grafting (with or
without valve replacement), who received 3 infusions of 0.2 g/kg of either &#x003c9;-3
PUFA or placebo at 12 hours and 2 hours before surgery and immediately after surgery.
Serial blood sampling and intraoperative atrial biopsy were carried out to assess oil
absorption by the cell membranes. Results showed that perioperative infusions
significantly increased the concentration of &#x003c9;-3 PUFA in platelet membrane and
atrial tissue within 12 hours of the first infusion and significantly lowered clinical
and biological signs of inflammation. In a recent meta-analysis (14 studies) on the use
of &#x003c9;-3 PUFA, Wang et al.<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>
showed promising results, with a lower incidence of POAF (RR 0.84 [95% CI 0.73-0.98],
<italic>P</italic>=0.03). These results, however, were only for coronary artery
bypass grafting (0.68 [0.47-0.97], <italic>P</italic>=0.03); none of the other types of
surgery analyzed showed similar results.</p><p>Moreover-and who would have thought-, studies have shown the benefits of vitamin C
(ascorbic acid) in preventing atrial fibrillation in the postoperative period of
cardiovascular surgery. A recent meta-analysis of 15 clinical trials for the prevention
of atrial fibrillation showed that in 9 of the studies vitamin C lowered the incidence
of postoperative atrial fibrillation (RR = 0.56 [95% CI 0.47-0.67],
<italic>P</italic>&#x0003c;0.01), and reduced the length of hospital stay by 12.6% (95% CI
8.4-16.8%, <italic>P</italic>&#x0003c;0.01) and in the intensive care unit by 8.0% (95% CI
3.0-13.0%, <italic>P</italic>&#x0003c;0.01). However, the authors found significant
differences in the possible effects of vitamin C to preventing postoperative atrial
fibrillation and they conclude that more research is needed to define protocols with a
precise dosage as well as to identify which groups of ideal patients could benefit the
most from its use<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>These alternatives become interesting in a global setting under constant change and
discussion. A case in point is the last year's guideline for perioperative medication
published by the European Association for Cardio-Thoracic Surgery (EACTS)<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>, which no longer recommends the routine
use of corticosteroids to control inflammation and prevent postoperative atrial
fibrillation in cardiovascular surgery, while the use of &#x003c9;-3 PUFA for this
purpose is already under discussion.</p><p>The constant search for postoperative metabolic and inflammation control in
cardiovascular surgery is justifiable, given the great impact on clinical outcomes, the
high costs, and the potential benefits that could be achieved with a more adequate
control. The original article conducted by Feguri et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>, available in this issue, gives the reader an
unprecedented association of preoperative fasting abbreviation with CHO and
intraoperative infusion of &#x003c9;-3 PUFA, as well as interesting results showing that
the method is safe. The authors also provide a brief review of this topic and highlight
the potential for faster postoperative recovery of patients undergoing on-pump coronary
artery bypass grafting.</p></body><back><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiessen</surname><given-names>S</given-names></name><name><surname>Vanhorebeek</surname><given-names>I</given-names></name><name><surname>Van den Berghe</surname><given-names>G</given-names></name></person-group><article-title>Glycemic control and outcome related to cardiopulmonary
bypass</article-title><source>Best Pract Res Clin Anaesthesiol</source><year>2015</year><month>6</month><volume>29</volume><issue>2</issue><fpage>177</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.bpa.2015.03.003</pub-id><pub-id pub-id-type="pmid">26060029</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feguri</surname><given-names>GR</given-names></name><name><surname>Lima</surname><given-names>PR</given-names></name><name><surname>Lopes</surname><given-names>AM</given-names></name><name><surname>Roledo</surname><given-names>A</given-names></name><name><surname>Marchese</surname><given-names>M</given-names></name><name><surname>Trevisan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Clinical and metabolic results of fasting abbreviation with
carbohydrates in coronary artery bypass graft surgery</article-title><source>Rev Bras Cir Cardiovasc</source><season>Jan-Mar</season><year>2012</year><volume>27</volume><issue>1</issue><fpage>7</fpage><lpage>17</lpage><comment>English, Portuguese</comment><pub-id pub-id-type="pmid">22729296</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langlois</surname><given-names>PL</given-names></name><name><surname>Hardy</surname><given-names>G</given-names></name><name><surname>Manzanares</surname><given-names>W</given-names></name></person-group><article-title>Omega-3 polyunsaturated fatty acids in cardiac surgery patients:
An updated systematic review and meta-analysis</article-title><source>Clin Nutr</source><month>6</month><year>2017</year><volume>36</volume><issue>3</issue><fpage>737</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2016.05.013</pub-id><pub-id pub-id-type="pmid">27293143</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar-Nascimento</surname><given-names>JE</given-names></name><name><surname>Bicudo-Salom&#x000e3;o</surname><given-names>B</given-names></name><name><surname>Caporosi</surname><given-names>C</given-names></name><name><surname>Silva</surname><given-names>RM</given-names></name><name><surname>Cardoso</surname><given-names>EA</given-names></name><name><surname>Santos</surname><given-names>TP</given-names></name></person-group><article-title>Enhancing surgical recovery in Central-West Brazil: the ACERTO
protocol results. e-SPEN</article-title><source>Eur J Clin Nutr Metab</source><year>2008</year><volume>3</volume><issue>2</issue><fpage>e78</fpage><lpage>e83</lpage><pub-id pub-id-type="doi">10.1016/j.eclnm.2008.01.003</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>MM</given-names></name><name><surname>Delodder</surname><given-names>F</given-names></name><name><surname>Liaudet</surname><given-names>L</given-names></name><name><surname>Tozzi</surname><given-names>P</given-names></name><name><surname>Schlaepfer</surname><given-names>J</given-names></name><name><surname>Chiolero</surname><given-names>RL</given-names></name><name><surname>Tappy</surname><given-names>L</given-names></name></person-group><article-title>Three short perioperative infusions of n-3 PUFAs reduce systemic
inflammation induced by cardiopulmonary bypass surgery: a randomized
controlled trial</article-title><source>Am J Clin Nutr</source><month>2</month><year>2013</year><volume>97</volume><issue>2</issue><fpage>246</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.3945/ajcn.112.046573</pub-id><pub-id pub-id-type="pmid">23269816</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name></person-group><article-title>N-3 polyunsaturated fatty acids for prevention of postoperative
atrial fibrillation: updated meta-analysis and systematic
review</article-title><source>J Interv Card Electrophysiol</source><month>3</month><year>2018</year><volume>51</volume><issue>2</issue><fpage>105</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1007/s10840-018-0315-5</pub-id><pub-id pub-id-type="pmid">29380237</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemil&#x000e4;</surname><given-names>H</given-names></name><name><surname>Suonsyrj&#x000e4;</surname><given-names>T</given-names></name></person-group><article-title>Vitamin C for preventing atrial fibrillation in high risk
patients: a systematic review and meta-analysis</article-title><source>BMC Cardiovasc Disord</source><day>01</day><month>2</month><year>2017</year><volume>17</volume><issue>1</issue><fpage>49</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1186/s12872-017-0478-5</pub-id><pub-id pub-id-type="pmid">28143406</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa-Uva</surname><given-names>M</given-names></name><name><surname>Milojevic</surname><given-names>M</given-names></name><name><surname>Head</surname><given-names>SJ</given-names></name><name><surname>Jeppsson</surname><given-names>A</given-names></name></person-group><article-title>The 2017 EACTS guidelines on perioperative medication in adult
cardiac surgery and patient blood management</article-title><source>Eur J Cardiothorac Surg</source><day>01</day><month>1</month><year>2018</year><volume>53</volume><issue>1</issue><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezx448</pub-id><pub-id pub-id-type="pmid">29240913</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feguri</surname><given-names>GR</given-names></name><name><surname>Lima</surname><given-names>PRL</given-names></name><name><surname>Franco</surname><given-names>AC</given-names></name><name><surname>La Cruz</surname><given-names>FRH</given-names></name><name><surname>Borges</surname><given-names>DC</given-names></name><name><surname>Toledo</surname><given-names>LR</given-names></name><etal/></person-group><article-title>Benefits of Fasting Abbreviation with Carbohydrates and Omega-3
Infusion During CABG: a Double-Blind Controlled Randomized
Trial</article-title><source>Braz J Cardiovasc Surg</source><year>2019</year><volume>34</volume><issue>2</issue><fpage>125</fpage><lpage>135</lpage></element-citation></ref></ref-list></back></article>